NL-OMON50794尚未招募不适用
AntiBody response in Risk groups to COrona Vaccination treated in the Adrz hospital: - AbriCoVa
Interne Geneeskunde0 个研究点目标入组 120 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 尚未招募
- 发起方
- 入组人数
- 120
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18 至 99（—）
入选标准
- •Study participant belongs to either of the 6 defined groups and is planned for
- •vaccination with the BNT162b2 or the mRNA1273 vaccine according to the National
- •Institute for Public Health guideline, i.e.:
- •Inflammatory bowel disease and on treatment for at least 6 weeks with
- •anti-TNF agents (infliximab, adalimumab and biosimilars)
- •post kidney transplantation and on immunosuppressants
- •Treated with B-cell depleting, antiCD20 (Obinituzumab or Rituximab)
- •monotherapy for a hematological malignancy in the past 6 months
- •Chronic lymphocytic leukemia (CLL), irrespective of stage, not treated for
- •CLL in the past 6 months prior to the first vaccination and no treatment
- •expected within 4 weeks of the second vaccination
- •Advanced solid malignancy and on treatment for at least 6 weeks with one or
- •more of the following agents: doxorubicin, cyclophosphamide, docetaxel,
- •cisplatinum, etoposide, irinotecan
- •healthy volunteers
- •Study participant is older than 17 years and willing to undergo vaccination
- •Study participant is able to give written informed consent
- •Study participant is able to visit the ADRZ for the scheduled laboratory
排除标准
- •History of a documented SARS COV-2 infection
- •Considered as high risk for a hypersensitivity reaction
研究者
相似试验
招募中
4 期
Antibody response to COVID-19 vaccination in immunosuppressed patients with autoimmune diseasePsoriatic arthritisAnkylosing spondylitisCOVID-19Inflammatory bowel diseaseInflammatory and Immune System - Autoimmune diseasesOral and Gastrointestinal - Crohn's diseaseOral and Gastrointestinal - Inflammatory bowel diseaseMusculoskeletal - Other muscular and skeletal disordersInfection - Other infectious diseasesInflammatory and Immune System - Other inflammatory or immune system disordersInflammatory and Immune System - Rheumatoid arthritisCrohn's DiseaseRheumatoid arthritisUlcerative ColitisACTRN12621000661875Dr Ai Tran100
招募中
不适用
EVEREST: Evaluation of COVID-19 Vaccination Efficacy and Rare Events in Solid TumoursACTRN12621001307897The Canberra Hospital200
进行中（未招募）
1 期
Immune response to COVID-19 Vaccination in people with Diabetes MellitusType 1 Diabetes MellitusType 2 Diabetes MellitusEUCTR2021-001459-15-ATMedical University of Graz161
进行中（未招募）
1 期
Response to corona vaccination in patients with primary Sjögren's syndromePrimary Sjögren's syndromeEUCTR2021-001414-10-NLniversity Medical Center Groningen180
已完成
4 期
Vaccine response against SARS-CoV-2 in patients with primary Sjögren*s syndrome1000381610047438Sjögren's syndromeNL-OMON51179niversitair Medisch Centrum Groningen180